Novo nordisk a/s class action alert: robbins llp reminds nvo stockholders of the pending lead plaintiff deadline

San diego, ca / access newswire / january 31, 2025 / robbins llp reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired novo nordisk a/s (nyse:nvo) securities between november 2, 2022 and december 19, 2024. novo is a healthcare company, focused on the research, development, manufacturing, and distribution of pharmaceutical productions globally.
NVO Ratings Summary
NVO Quant Ranking